
Releases
WuXi Biologics Claims Top Sustainability Honors at The Asset Awards 2026
WuXi Biologics has secured the prestigious Jade Award at The Asset Corporate Sustainability Leadership Awards 2026, distinguishing itself as the sole pharmaceutical company to achieve the program’s highest honor. The organization also received the Best in Transition (Hong Kong) title, marking a significant milestone in its ongoing green and digital transformation.


























